IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$476.27 USD
+2.99 (0.63%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $476.27 0.00 (0.00%) 5:46 PM ET
4-Sell of 5 4
D Value C Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$476.27 USD
+2.99 (0.63%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $476.27 0.00 (0.00%) 5:46 PM ET
4-Sell of 5 4
D Value C Growth D Momentum D VGM
Zacks News
Can the Rally in IDEXX Laboratories (IDXX) Shares Continue?
by Zacks Equity Research
IDEXX Laboratories, Inc. (IDXX) has been on the move lately as the stock has risen by 16.5% in the past four weeks, and it is currently trading well above its 20-Day SMA
Looking for a Growth Stock? Why It is Time to Focus on IDEXX Laboratories (IDXX)
by Zacks Equity Research
IDEXX Laboratories (IDXX) is seeing solid earnings estimate revision and has a favorable Zacks rank, making it well positioned for future earnings growth.
IDEXX Laboratories (IDXX) Q4 Earnings Rise; Tweaks View
by Zacks Equity Research
IDEXX Laboratories Inc. (IDXX) recorded fourth-quarter 2016 earnings per share (EPS) of 58 cents, up 21% year over year on a reported basis.
IDEXX Laboratories (IDXX) Beats Q4 Revenues, Y/Y EPS rises
by Zacks Equity Research
IDEXX Laboratories (IDXX) has seen growth in earnings year over year and has beaten the Zacks Consesnus Estimate in terms of revenue.
Medical Product Earnings Due on Feb 2: BDX, BSX, IDXX, ATHN
by Zacks Equity Research
The medical sector is likely to see 2.9% earnings growth on 5.7% higher revenues in the quarter.
IDEXX Laboratories (IDXX) Q4 Earnings: What's in Store?
by Zacks Equity Research
IDEXX Laboratories, Inc. (IDXX) is slated to report fourth-quarter 2016 results on Feb 2, before the opening bell.
IDEXX Laboratories (IDXX) Set to Join the S&P 500 Index
by Zacks Equity Research
IDEXX Laboratories, Inc. (IDXX) is scheduled to join the coveted S&P 500 benchmark, after the market closes on Jan 4.
Neogen (NEOG) Acquires Brazilian Private Company Rogama
by Zacks Equity Research
Neogen Corporation (NEOG) announced that it has acquired Brazil-based Rogama Industria e Comercio Ltda.
Patterson and ADPI Extend Partnership for Dental Platform
by Zacks Equity Research
Patterson Companies Inc. (PDCO), a leading distributor and seller of dental and animal health products, announced that it has extended its partnership with American Dental Partners or ADPI.
Mazor Robotics Receives Order for Three Mazor X Systems
by Zacks Equity Research
Israel-based developer of robotic technology and products, Mazor Robotics Ltd. (MZOR), recently announced a three-system order for the Mazor X, from a leading mid-Atlantic health care organization.
Cardinal Health to Pay $44M as Civil Penalty Settlement
by Zacks Equity Research
Cardinal Health Inc. (CAH) announced that it would shell out $44 million as civil penalties for a 2012 administrative settlement with the U.S. Drug Enforcement Agency or DEA.
Varian to Acquire PerkinElmer's Medical Imaging Business
by Zacks Equity Research
Varian Medical Systems, Inc. (VAR) recently announced an agreement to takeover the Medical Imaging business of Waltham, MA-based PerkinElmer, Inc. (PKI) for $276 million.
DaVita Ties Up With WellHealth, Expands in Southern Nevada
by Zacks Equity Research
DaVita HealthCare Partners Inc. (DVA), a leading provider of dialysis services, announced that HealthCare Partners Nevada, a unit within its medical group, has acquired WellHealth Quality Care.
Fluidigm Unveils High-Throughput Integrated Fluidic Circuit
by Zacks Equity Research
Fluidigm Corporation (FLDM), a leading player in the analysis of single cells and industrial application of genomics, recently unveiled a new high-throughput integrated fluidic circuit (HT IFC) to separate single cells during mRNA sequencing analysis.
WebMD Health (WBMD) Repurchaces 2 Million Common Shares
by Zacks Equity Research
WebMD Health Corp. (WBMD) announced that it has completed a tender offer to purchase 2 million shares of its common stock.
Accuray: Hong Kong Sanatorium to Buy 3 Radixact Systems
by Zacks Equity Research
Accuray Incorporated (ARAY) has signed an agreement with Hong Kong Sanatorium & Hospital per which the latter would purchase three Radixact Systems.
Meridian Bioscience Partners MedCaptain, Expands in China
by Zacks Equity Research
Meridian Bioscience, Inc. (VIVO) announced that its Magellan Diagnostics business has signed a distribution agreement with China-based MedCaptain Medical Technology.
DexCom (DXCM) Gains FDA Approval for G5 Mobile CGM System
by Zacks Equity Research
San Diego, CA-based DexCom, Inc. (DXCM), a renowned medical device company, announced the U.S. FDA approval for its G5 Mobile CGM (continuous glucose monitoring) system.
Luminex Awarded R&D 100 for ARIES Systems in November
by Zacks Equity Research
Luminex Corporation (LMNX) announced that its ARIES Systems was awarded the R&D 100 Award at the 54th Annual R&D 100 Awards ceremony in November.
Allscripts Buys Core Medical Solutions, Expands in Australia
by Zacks Equity Research
Allscripts Healthcare Solutions, Inc. (MDRX), a leading global provider of information technology and services to healthcare organizations, recently announced the acquisition of Core Medical Solutions to expand its offerings in Australia.
Envision Healthcare Ties Up with Alabama Neonatal Medicine
by Zacks Equity Research
Envision Healthcare Corporation (EVHC) announced the acquisition of Alabama Neonatal Medicine, P.C. and the extension of its Women's and Children's Services specialty.
Neogen (NEOG) to Buy Quat-Chem, Shares Hit 52-Week High
by Zacks Equity Research
Neogen Corporation (NEOG), recently announced the acquisition of United Kingdom-based Quat-Chem Ltd., a chemical company which develops, manufactures and sells agricultural, industrial, and food processing biocidal hygiene products.
Varian (VAR) in Just 100 List from JUST Capital and Forbes
by Zacks Equity Research
Varian Medical Systems Inc. (VAR) announced it was included in the inaugural JUST 100 List.
Veeva Systems Set to Grow on Subscription Revenue Focus
by Zacks Equity Research
On Nov 30, we issued an updated research report on Pleasanton, CA-based Veeva Systems Inc. (VEEV).
TrovaGene Inks Contract with Boreal Genomics, Stock Down
by Zacks Equity Research
TrovaGene Inc. (TROV), a molecular diagnostic company, recently announced the signing of a long-term Supply and Distribution Agreement with Boreal Genomics.